Bright Minds Biosciences, Inc. (DRUG)
66.91
+1.75
(+2.69%)
USD |
NASDAQ |
Sep 08, 16:00
67.50
+0.59
(+0.88%)
Pre-Market: 08:05
Bright Minds Biosciences Market Cap : 660.01M for Sept. 8, 2026
Market Cap Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Market Cap Data
| Date | Value |
|---|---|
| September 08, 2026 | 660.01M |
| September 04, 2026 | 642.74M |
| September 03, 2026 | 670.96M |
| September 02, 2026 | 701.53M |
| September 01, 2026 | 698.77M |
| August 31, 2026 | 707.55M |
| August 28, 2026 | 718.21M |
| August 27, 2026 | 735.22M |
| August 26, 2026 | 755.89M |
| August 25, 2026 | 784.10M |
| August 24, 2026 | 759.78M |
| August 21, 2026 | 763.68M |
| August 20, 2026 | 774.92M |
| August 19, 2026 | 835.88M |
| August 18, 2026 | 828.98M |
| August 17, 2026 | 784.00M |
| August 14, 2026 | 754.01M |
| August 13, 2026 | 769.40M |
| August 12, 2026 | 782.91M |
| August 11, 2026 | 787.42M |
| August 10, 2026 | 792.72M |
| August 07, 2026 | 778.39M |
| August 06, 2026 | 792.82M |
| August 05, 2026 | 784.97M |
| August 04, 2026 | 758.97M |
| Date | Value |
|---|---|
| August 03, 2026 | 723.94M |
| July 31, 2026 | 718.83M |
| July 30, 2026 | 732.28M |
| July 29, 2026 | 697.25M |
| July 28, 2026 | 706.08M |
| July 27, 2026 | 705.59M |
| July 24, 2026 | 699.90M |
| July 23, 2026 | 699.50M |
| July 22, 2026 | 740.42M |
| July 21, 2026 | 758.38M |
| July 20, 2026 | 732.08M |
| July 17, 2026 | 746.90M |
| July 16, 2026 | 728.35M |
| July 15, 2026 | 744.93M |
| July 14, 2026 | 726.39M |
| July 13, 2026 | 745.03M |
| July 10, 2026 | 763.77M |
| July 09, 2026 | 767.31M |
| July 08, 2026 | 685.67M |
| July 07, 2026 | 634.25M |
| July 06, 2026 | 653.98M |
| July 02, 2026 | 663.30M |
| July 01, 2026 | 652.90M |
| June 30, 2026 | 688.81M |
| June 29, 2026 | 678.80M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Agenus, Inc. | 316.63M |
| Amgen, Inc. | 212.55B |
| Anika Therapeutics, Inc. | 281.58M |
| BioCryst Pharmaceuticals, Inc. | 2.314B |
| Imunon, Inc. | 7.185M |
Market Cap Related Metrics
| PEG Ratio | -0.2671 |
| Price to Book Value | 3.042 |
| Price | 66.91 |
| Earnings Yield | -3.12% |
| PEGY Ratio | -0.2671 |